Neogen (NEOG) Stock Overview
Develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NEOG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Neogen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.50 |
| 52 Week High | US$17.96 |
| 52 Week Low | US$3.87 |
| Beta | 1.85 |
| 1 Month Change | 1.29% |
| 3 Month Change | -2.48% |
| 1 Year Change | -65.90% |
| 3 Year Change | -65.86% |
| 5 Year Change | -85.42% |
| Change since IPO | 2,052.14% |
Recent News & Updates
Recent updates
Neogen: A Nibble With The Sale Of An Out-Of-The-Money Call That Can Be Rolled Forward
Sep 08Is Neogen (NASDAQ:NEOG) Using Too Much Debt?
Jul 10
Food Safety And Genomics Will Expand Global Markets
Resilient core businesses, strategic divestitures, and efficiency initiatives are expected to stabilize revenue and expand margins as macro and operational conditions improve.Improved Revenues Required Before Neogen Corporation (NASDAQ:NEOG) Stock's 33% Jump Looks Justified
May 16Neogen: A Fair Divestment (Rating Upgrade)
Apr 23Here's Why Neogen (NASDAQ:NEOG) Is Weighed Down By Its Debt Load
Apr 11Neogen: Food Safety Play Is Far From A Safe Pay
Jan 14Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)
Dec 03Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?
Nov 07Neogen Stock: Expect Volatility To Continue Amid Weak Growth
Oct 11Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)
Aug 28We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt
Jul 31Neogen Corporation: Challenges Remain
Jun 26There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price
May 21Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Shareholder Returns
| NEOG | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.3% | -1.8% | 1.7% |
| 1Y | -65.9% | 0.6% | 18.7% |
Return vs Industry: NEOG underperformed the US Medical Equipment industry which returned 0.4% over the past year.
Return vs Market: NEOG underperformed the US Market which returned 18.5% over the past year.
Price Volatility
| NEOG volatility | |
|---|---|
| NEOG Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NEOG has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NEOG's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,974 | Mike Nassif | www.neogen.com |
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
Neogen Corporation Fundamentals Summary
| NEOG fundamental statistics | |
|---|---|
| Market cap | US$1.19b |
| Earnings (TTM) | -US$1.09b |
| Revenue (TTM) | US$894.66m |
Is NEOG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEOG income statement (TTM) | |
|---|---|
| Revenue | US$894.66m |
| Cost of Revenue | US$473.29m |
| Gross Profit | US$421.38m |
| Other Expenses | US$1.51b |
| Earnings | -US$1.09b |
Last Reported Earnings
May 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.03 |
| Gross Margin | 47.10% |
| Net Profit Margin | -122.06% |
| Debt/Equity Ratio | 43.1% |
How did NEOG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/14 15:05 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/05/31 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Neogen Corporation is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Westenberg | CL King & Associates, Inc. |
| Steven Crowley | Craig-Hallum Capital Group LLC |
| Paul Knight | Credit Agricole Securities (USA) Inc. |